Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stanford University
Participants with chronic kidney disease will undergo two 1-week study periods (single-dose diuretic versus single-dose placebo) separated by 1-2 weeks of washout in a cross-over design. Blood and urine samples will be collected at the end of each study period to determine the effect on urine output and to assess the kidney clearance and levels of uremic solute. Participants will weigh themselves daily.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
stable chronic kidney disease patients able to provide consent
stable dialysis patients who produce urine and able to provide consent
You may not be if
use of antibiotics for last two months or expected antibiotic use
recent hospitalization or other event resulting in instability of food intake
